Feasibility and resource utilization of nurse-administered subcutaneous immunoglobulin therapy in antibody deficiency: A cross-sectional study.
Primary and secondary antibody deficiencies (PAD and SAD) are amongst the most prevalent immunodeficiency syndromes, often necessitating long-term immune globulin replacement therapy (IRT). Both intravenous immunoglobulin (IVIG) and subcutaneous immunoglobulin (SCIG) have demonstrated efficacy in an...
Saved in:
| Main Authors: | Darshee Ghia, Pranavi Thota, Taylor Ritchie, Heli Rana, Ranvir Minhas, Jalal Moolji, Bruce Ritchie, Adil Adatia |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0316797 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Disease control and disease activity in hereditary angioedema: two sides of the same coin?
by: Behzad Heibati, et al.
Published: (2025-07-01) -
Current experience with manual push subcutaneous immunoglobulin (SCIg) in patients with immune deficiencies
by: Alex Richter
Published: (2025-06-01) -
Factors Affecting the Absorption of Subcutaneously Administered Insulin: Effect on Variability
by: A. K. J. Gradel, et al.
Published: (2018-01-01) -
Infectious outcomes of a standardized subcutaneous immunoglobulin dose reduction strategy in primary immune deficiencies amid global shortage
by: Pedro Moral Moral, et al.
Published: (2025-01-01) -
Pharmacokinetic profile and in vivo anticancer efficacy of anagrelide administered subcutaneously in rodents
by: Kirsi Toivanen, et al.
Published: (2025-12-01)